Skin Graft Market to Grow at a CAGR of 7.0% to reach US$ 1,673.5 million from 2021 to 2028

The skin graft market was valued at US$ 985.4 million in 2020 and is projected to reach US$ 1,673.5 million by 2028; it is expected to grow at a CAGR of 7.0% from 2021 to 2028.

Skin grafting is a surgery involving the transplantation of skin using various types of skin graft. Skin grafts are also used to treat extensive wounding or trauma and burns. In Skin skin grafting procedure,  is a small patch of the skin, which is  is removed from a patient’s body part and attached to or transplanted to the affected area of the body removed from skin of the other part of the patient’s body by a surgery. The patch of skin is transplanted or attached to the injured sit or the burnt site.
 
The skin graft market is segmented on the basis of product, graft thickness, application, equipment, end-users, and region. The market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the skin graft market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID–19 pandemic on the market across all the regions. Due to the outbreak of COVID-19 outbreak, various hospitals were are engaged in treating the affected infected people. Additionally As,  various wound care centers are located in operate from hospitals. , Hence, majority of the patients did not are unable to receive the wound care treatment. ~ Approximately 1 in 4 patients is able to receives wound care treatment, and it is expected that there are nearly 6.7 million people across the US those are waiting for the wound treatment. Researchers evaluated the stability of SARS-CoV-2 and influenza A virus (IAV), mixed with culture medium or upper respiratory mucus, on human skin surfaces, and the dermal disinfection effectiveness of 80 per cent (w/w) ethanol against SARS-CoV-2 and IAV. To avoid infecting healthy volunteers, researchers conducted lab experiments using cadaver skin that would have otherwise been used for skin grafts. The outbreak of COVID-19 outbreak has negatively impacted the skin graft market profoundly by affecting the quality care.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Skin Graft Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Rising Prevalence of Skin Cancer and Diabetes

Skin grafts are ideally preferred post-surgery for skin cancers. Skin grafts are generally referred for local postoperative radiotherapy (PORT) to ensure closure of surgical bed created during radiotherapy. According to Cancer Research UK, ~15,400 new melanoma skin cancer cases are registered in the UK every year, accounting for 42 new cases every day. Incidence rates for melanoma skin cancer are projected to rise by 7% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035. Likewise, according to the recent statistics published by the International Agency for Research on Cancer, in 2020, 19.3 million new cancer cases were registered, excluding 18.1 million for nonmelanoma skin cancer. Thus, an increase in the prevalence of skin cancer is likely to contribute to skin grafting in the coming future.

Diabetes is among the most common health conditions prevalent across the globe. According to the International Diabetes Federation’s (IDF) IDF Diabetes Atlas Ninth edition 2019, ~463 million adults were living with diabetes worldwide. The prevalence is estimated to be 700 million by 2045—nearly 79% of adults living with diabetes in low-and-middle incomes countries worldwide. Among the prevalence of diabetes, the proportion of type 2 diabetes is increasing at a much faster rate. According to the IDF, 374 million are at risk of developing type 2 diabetes in the coming future. Among diabetic patients, wound healing is prolonged, which increases the risk of skin infections if it is not healed within a particular time. ~25% of diabetic patients are likely to develop foot ulcers once in their lifetime that often need advanced diabetic wound care. Therefore, there is an increase in demand for skin grafts to treat or cover diabetic foot ulcers by eliminating the chances of contracting skin infections. Thus, the high prevalence rate of skin cancer and diabetes is expected to drive skin graft market in the near future.
 

Product -Based Insights

Based on type, the skin graft market is segmented segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. The autologous segment accounted for held the global pharmaceutical intermediate market's the largest market share in 2020, and the market for the same segment market is anticipated to grow faster at the highest rate during 2021–2028. The market growth for autologous segment can be attributed to the wide use of autologous grafts are used widely for treating open burns and wounds.
 

Application-Based Insights

Based on application, the skin graft market is segmented into burns, extensive wound, skin cancer, and other applications. The burns segment held the largest share of the market in 2020. and The same segment is estimated to register the highest CAGR in the market during the forecast period.
Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater to meet changing customer demand and maintain their brand name across the world. Market players operating in the skin graft market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

Skin Graft Market Regional Insights

The regional trends and factors influencing the Skin Graft Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Skin Graft Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Skin Graft Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Skin Graft Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Skin Graft Market are:

1. B. Braun Melsungen AG
2. Integra Life Sciences Corporation
3. Smith & Nephew
4. AVITA Medical
5. MiMedx

Disclaimer: The companies listed above are not ranked in any particular order.

By Product

• Autologous
• Allogeneic
• Xenogeneic
• Prosthetic
• Isogeneic

By Graft Thickness                          

• Split-Thickness
• Full-Thickness
• Composite Graft

By Application                                 

• Burns
• Extensive Wound
• Skin Cancer
• Other Applications

By Equipment                                 

• Dermatome
• General Surgical Instruments
• Consumables
• Others Market

By End Users                                  

• Hospitals
• Ambulatory Surgical Centers
• Dermatology Clinics

By Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• B. Braun Melsungen AG
• Integra Life Sciences Corporation
• Smith & Nephew
• AVITA Medical
• MiMedx
• Organogenesis Inc
• Tissue Regenix Group
• Zimmer Biomet
• De Soutter Medical
• Nouvag AG